Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962)

Journal of Enzyme Inhibition
J O JohnstonH D Benson

Abstract

MDL 18,962, 19-acetylenic androstenedione, is an enzyme-activated inhibitor of estrogen biosynthesis which is in Phase I clinical evaluations as a potential therapeutic agent for estrogen-dependent cancers. 19-Acetylenic analogs corresponding to the major metabolites of androstenedione were synthesized as potential metabolites of MDL 18,962. These compounds were 19-acetylenic testosterone, the product of 17 beta-hydroxy steroid oxidoreductase, 6 beta-hydroxy- and 6-oxo-19-acetylenic androstenedione, products of P450 steroid 6 beta-hydroxylase and alcohol dehydrogenase, respectively. All of these analogs showed time-dependent inactivation of human placental aromatase activity. The time-dependent Ki and t1/2 at infinite inhibitor concentration (tau 50) were 4.3 nM, 12.0 min for MDL 18,962; 28 nM, 7.8 min for 17-hydroxy analog; 13 nM, 37 min for 6 beta-hydroxy analog; and 167 nM, 6.1 min for the 6-oxo analog. The 19-acetylenic testosterone, a confirmed metabolite from primate studies, was 25% as efficient as MDL 18,962 for aromatase inactivation, while 6 beta-hydroxy- and 6-oxo analogs were 11% and 5%, respectively as efficient as their parent compound. These data indicate that first-pass metabolism of MDL 18,962 does not cause an...Continue Reading

References

Nov 1, 1986·Journal of Steroid Biochemistry·D HendersonM F el Etreby
Oct 1, 1989·Journal of Steroid Biochemistry·J O JohnstonR C Shumaker
Oct 15, 1987·Biochemical Pharmacology·M S Bitar, B H Shapiro
Nov 1, 1986·Journal of Steroid Biochemistry·A M BrodieR C Coombes
Mar 1, 1985·Steroids·J P BurkhartJ O Johnston
Jan 1, 1980·Drug Metabolism Reviews·R L Felsted, N R Bachur
Sep 1, 1981·European Journal of Biochemistry·P KremersJ E Gielen

❮ Previous
Next ❯

Citations

Jan 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·J O JohnstonG W Holbert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.